Association of initial cisplatin dose with treatment-related toxicity and survival in elderly patients with locally advanced head and neck squamous cell carcinoma

Background Cisplatin-based chemoradiotherapy (CRT) is standard for locally advanced head and neck squamous cell carcinoma (HNSCC), but the optimal initial cisplatin dose for elderly patients remains unclear.Aims/objectives To investigate the association between initial cisplatin dose, toxicity, and prognosis in elderly patients with HNSCC.Material and methods We retrospectively reviewed 58 patients with HNSCC treated with definitive CRT using triweekly cisplatin at 100 mg/m2 (high-dose) or 80 mg/m2 (low-dose). Outcomes were compared between groups, including age-based subgroup analyses.Results Overall survival was poorer in the high-dose group (p < 0.05). Among elderly patients, severe toxicity occurred in 35.7% and 9.1% of the high- and low-dose groups, respectively. Among elderly patients with recurrence, severe toxicity occurred in 4/4 and 1/8 patients, respectively (p < 0.05). The high-dose group also showed greater declines in body weight and body mass index during and poorer survival after second-line treatment (p < 0.01). Advanced disease and higher modified Glasgow Prognostic Score were associated with severe toxicity (p < 0.05).Conclusions and significance Higher initial cisplatin doses were associated with greater toxicity and poorer survival in elderly patients. Pretreatment nutritional and inflammatory status may help guide cisplatin dose selection.

Authors

Institutions

Publication Details

Journal
Acta Oto-Laryngologica
Published
2026-11-18
DOI
https://doi.org/10.1080/00016489.2026.2759217
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of initial cisplatin dose with treatment-related toxicity and survival in elderly patients with locally advanced head and neck squamous cell carcinoma

Tomohiro Hasegawa, Ryoukichi Ikeda, Masashi Kuroki, Takenori Ogawa et al.
3 links
Acta Oto-Laryngologica
Head and Neck Cancer Studies
article

Association of initial cisplatin dose with treatment-related toxicity and survival in elderly patients with locally advanced head and neck squamous cell carcinoma

Tomohiro Hasegawa, Ryoukichi Ikeda, Masashi Kuroki, Takenori Ogawa, Hirofumi Shibata, Ryota Iinuma, Ryo Kawaura, Hiroshi Okuda
article en

Abstract

Background Cisplatin-based chemoradiotherapy (CRT) is standard for locally advanced head and neck squamous cell carcinoma (HNSCC), but the optimal initial cisplatin dose for elderly patients remains unclear.Aims/objectives To investigate the association between initial cisplatin dose, toxicity, and prognosis in elderly patients with HNSCC.Material and methods We retrospectively reviewed 58 patients with HNSCC treated with definitive CRT using triweekly cisplatin at 100 mg/m2 (high-dose) or 80 mg/m2 (low-dose). Outcomes were compared between groups, including age-based subgroup analyses.Results Overall survival was poorer in the high-dose group (p < 0.05). Among elderly patients, severe toxicity occurred in 35.7% and 9.1% of the high- and low-dose groups, respectively. Among elderly patients with recurrence, severe toxicity occurred in 4/4 and 1/8 patients, respectively (p < 0.05). The high-dose group also showed greater declines in body weight and body mass index during and poorer survival after second-line treatment (p < 0.01). Advanced disease and higher modified Glasgow Prognostic Score were associated with severe toxicity (p < 0.05).Conclusions and significance Higher initial cisplatin doses were associated with greater toxicity and poorer survival in elderly patients. Pretreatment nutritional and inflammatory status may help guide cisplatin dose selection.

Acta Oto-Laryngologica
Gifu University Hospital (JP), Gifu University (JP)
Good health and well-being
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon